Efficacy and Safety of Dabigatran Compared With Warfarin in Patients With Atrial Fibrillation and Normal Renal Function Over Time: Insights From the RE-LY Trial

被引：0

作者：

Hijazi, Ziad

Hohnloser, Stefan H.

Oldgren, Jonas

Andersson, Ulrika

Connolly, Stuart J.

Eikelboom, John W.

Ezekowitz, Michael D.

Reilly, Paul A.

Yusuf, Salim

Wallentin, Lars

机构：

来源：

关键词：

Anticoagulation; Dabigatran; Atrial fibrillation; Renal function; Stroke;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

17126

引用

页数：4